Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor

被引:44
|
作者
Bosch, MP [1 ]
Campos, F
Niubó, I
Rosell, G
Díaz, JL
Brea, J
Loza, MI
Guerrero, A
机构
[1] CSIC, IIQAB, Dept Biol Organ Chem, ES-08034 Barcelona, Spain
[2] Univ Barcelona, Dept Pharmacol & Med Sci, CSIC, Fac Pharm, E-08028 Barcelona, Spain
[3] Lab Almirall Prodesfarma, Barcelona 08024, Spain
[4] Univ Santiago de Compostela, Fac Pharm, Dept Pharmacol, Santiago De Compostela 1578, Spain
关键词
D O I
10.1021/jm031143+
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
New adenosine derivatives have been synthesized and tested as putative agonists of adenosine receptors. Compounds 2-6 derive from the introduction of several types of substituents (electron donating, electron withdrawing, and halogens) in the para-position of the phenyl ring of the parent compound 1, and compound 7 lacks the hydroxyl group of amino alcohol 1. In radioligand binding assays using recombinant human A(1), A(2A), A(2B), and A(3) receptors, all compounds showed very low or negligible affinity for A(1) and A(2B) receptors but compounds 3, 5, and 7 displayed a remarkably potent affinity for the A2A receptor with K-i values of 1-5 nM. Bromo derivative 3 displayed a selectivity A(1)/A(2A) = 62 and A(3)/A(2A) = 16 whereas the presence of a hydroxyl group (compound 5) improved the selectivity of A(1)/A(2A) and A(3)/A(2A) to 120- and 28-fold, respectively. When the methoxy derivative 4 lacks the hydroxyl group on the side chain (compound 7), the binding affinity for A(2A) is increased to 1 nM, improving selectivity ratios to 356- and 100-fold against A(1) and A(3), respectively. In Chinese hamster ovary cells transfected with human A2A and A(2B) receptors, most compounds showed a remarkable activity for the A2A receptor, except chloro derivative 2, with EC50 values ranging from 1.4 to 8.8 nM. The compounds behaved as good A(2A) agonists, and all were more selective than 5'-(N-ethylearboxamino)adenosine (NECA), with A(2B)/A(2A) ratios of cAMP accumulation ranging from 48 for compound 2 to 666 for compound 7 while the corresponding A(2B)/A(2A) ratio for NECA was only 9. Compounds 1, 3, 5, and 7 also displayed higher selectivities than NECA up to 100-fold in isolated aortas of rat and guinea pig. In guinea pig tracheal rings precontracted by carbachol, compounds 2 and 4 were more potent than adenosine (100-fold) and NECA (10-fold), whereas compounds 1 and 7 displayed similar effects to NECA. Pretreatment of the tracheal rings with A(2), A(2A), and A(2B) receptor antagonists 3,7-dimethyl-L-propargylxanthine, 8-(3-chlorostyryl)caffeine, and alloxazine produced a marked inhibition of the tracheal relaxations induced by compounds 1, 2, and 4, but none of the compounds showed selectivity toward any of the adenosine receptors.
引用
收藏
页码:4041 / 4053
页数:13
相关论文
共 50 条
  • [41] Adenosine A2a receptor agonists as regulators of inflammation: pharmacology and therapeutic opportunities
    Morello, Silvana
    Sorrentino, Rosalinda
    Pinto, Aldo
    JOURNAL OF RECEPTOR LIGAND AND CHANNEL RESEARCH, 2009, 2 : 11 - 17
  • [42] Pharmacologic characterization of novel adenosine A2A receptor agonists in equine neutrophils
    Sun, Wan-Chun
    Moore, James N.
    Hurley, David J.
    Vandenplas, Michel L.
    Linden, Joel M.
    Murray, Thomas F.
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2007, 68 (09) : 981 - 987
  • [43] Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A2A receptor agonists
    Sullivan, GW
    Rieger, JM
    Scheld, WM
    Macdonald, TL
    Linden, J
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (05) : 1017 - 1026
  • [44] Design, synthesis and biological evaluation of 2-hydrazinyladenosine derivatives as A2A adenosine receptor ligands
    Zhang, Min
    Fan, Shiyong
    Zhou, Xinbo
    Xie, Fei
    Li, Song
    Zhong, Wu
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 179 : 310 - 324
  • [45] Adenosine A2A receptor as a potential new therapeutic target for the prevention/treatment of osteoarthritis
    Corciulo, Carmen
    Mediero, Aranzazu
    Wilder, Tuere
    Cronstein, Bruce
    PURINERGIC SIGNALLING, 2014, 10 (04) : 808 - 809
  • [46] Adenosine A2A Receptor As a Potential New Therapeutic Target For The Prevention/Treatment Of Osteoarthritis
    Mediero, Aranzazu
    Wilder, Tuere
    Cronstein, Bruce N.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S21 - S21
  • [47] A2A Adenosine Receptor Antagonists and their Potential in Neurological Disorders
    Lambertucci, Catia
    Marucci, Gabriella
    Catarzi, Daniela
    Colotta, Vittoria
    Francucci, Beatrice
    Spinaci, Andrea
    Varano, Flavia
    Volpini, Rosaria
    CURRENT MEDICINAL CHEMISTRY, 2022, 29 (28) : 4780 - 4795
  • [48] The discovery and synthesis of highly potent, A2a receptor agonists
    Keeling, SE
    Albinson, FD
    Ayres, BE
    Butchers, PR
    Chambers, CL
    Cherry, PC
    Ellis, F
    Ewan, GB
    Gregson, M
    Knight, J
    Mills, K
    Ravenscroft, P
    Reynolds, LH
    Sanjar, S
    Sheehan, MJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (04) : 403 - 406
  • [49] Loss of constitutive activity is correlated with increased thermostability of the human adenosine A2A receptor
    Bertheleme, Nicolas
    Singh, Shweta
    Dowell, Simon J.
    Hubbard, Julia
    Byrne, Bernadette
    BRITISH JOURNAL OF PHARMACOLOGY, 2013, 169 (05) : 988 - 998
  • [50] Functional efficacy of adenosine A2A receptor agonists is positively correlated to their receptor residence time
    Guo, Dong
    Mulder-Krieger, Thea
    IJzerman, Adriaan P.
    Heitman, Laura H.
    BRITISH JOURNAL OF PHARMACOLOGY, 2012, 166 (06) : 1846 - 1859